Drug Trial Radar · NCT07011745
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
426
Planned (sponsor's estimate)
Start
Jul 16, 2025
Primary completion
Nov 3, 2028
Study completion Nov 13, 2028
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Jun 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 55 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.
Conditions
- Alzheimer's Disease
Interventions
Xanomeline/Trospium Chloride CapsuleDrug
Specified dose on specified days
Xanomeline Enteric CapsuleDrug
Specified dose on specified days
PlaceboDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline on the Cohen-Mansfield Agitation Inventory-International Psychogeriatric Association (CMAI-IPA) total score at Week 14Time frame: At Week 14
Locations
143 sites in 14 countries. Site status is shown where the registry gives one.
Chandler Clinical Trials, LLC
Chandler, Arizona · Recruiting
Local Institution - 2631
Chandler, Arizona · Not yet recruiting
TrialSphere Corp
Chandler, Arizona · Recruiting
National Institute of Clinical Research
Garden Grove, California · Recruiting
Local Institution - 2607
Long Beach, California · Not yet recruiting
Accellacare
Long Beach, California · Recruiting
Local Institution - 2627
Napa, California · Not yet recruiting
ATP Clinical Research
Orange, California · Recruiting
Local Institution - 2613
Pasadena, California · Not yet recruiting
Local Institution - 2614
San Diego, California · Not yet recruiting
Local Institution - 2620
West Hills, California · Completed
Local Institution - 2601
Basalt, Colorado · Withdrawn
Local Institution - 2632
Norwalk, Connecticut · Not yet recruiting
Visionary Investigators Network
Aventura, Florida · Recruiting
Envision Trials LLC
Bonita Springs, Florida · Recruiting
Key Clinical Research
Bradenton, Florida · Recruiting
Local Institution - 2636
Doral, Florida · Not yet recruiting
Local Institution - 2606
Homestead, Florida · Not yet recruiting
Miami Jewish health
Miami, Florida · Recruiting
Local Institution - 2637
Miami, Florida · Not yet recruiting
Local Institution - 2634
Orlando, Florida · Not yet recruiting
IPTB Clinical Research
Tampa, Florida · Recruiting
Agile Clinical Research Trials, LLC
Atlanta, Georgia · Recruiting
Local Institution - 2615
Worcester, Massachusetts · Completed
Local Institution - 2618
Ann Arbor, Michigan · Completed
Local Institution - 2630
Saint Paul, Minnesota · Not yet recruiting
Hattiesburg Clinic
Hattiesburg, Mississippi · Recruiting
Local Institution - 2603
Ozark, Missouri · Completed
Las Vegas Clinical Trials
Las Vegas, Nevada · Recruiting
Bio Behavioral Health
Toms River, New Jersey · Recruiting
Local Institution - 2647
Brooklyn, New York · Not yet recruiting
Richmond Behavioral Associates
Staten Island, New York · Recruiting
Walnut Clinical Research
Valley Stream, New York · Recruiting
West Clinical Research
Morehead City, North Carolina · Recruiting
Velocity Clinical Research - Blue Ash
Blue Ash, Ohio · Recruiting
Epic Medical Research, LLC - Carrolton
Carrollton, Texas · Recruiting
Horizon Clinical Research Center - Houston
Cypress, Texas · Recruiting
Epic Medical Research, LLC - Mesquite
Mesquite, Texas · Recruiting
UT Health - San Antonio
San Antonio, Texas · Recruiting
Local Institution - 2612
Bountiful, Utah · Completed
Showing 40 of 143 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.